Laura Konczal
Clinical Genetics (M.D.) · Cleveland, OHNPI 1316141492
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,074 of the $47,437 with a category attached, or 73.9%. Ultragenyx Pharmaceutical Inc. accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $30,839 and has fallen 56.8% since, to $13,319 in 2025. Among clinical genetics (m.d.) clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $862.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$47K
- Sanofi$43
- PTC Therapeutics, Inc.$35
Across 104 payments — averaging $6561.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$513K
- Amgen$68K
- Soleno Therapeutics, Inc.$44K
- Sanofi$31K
- Modernatx, Inc.$24K
- Sanofi US Services Inc.$3K
What the payments were for
- Consulting fees$3,2007%
- Speaking & faculty fees$35,07474%
- Travel & lodging$8,18317%
- Food & beverage$9452%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 52 | $47,359 |
| Sanofi | 2 | $43 |
| PTC Therapeutics, Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOJOLVI$23,854
How this compares
$47,437 in reported general payments places this provider in the 90th percentile of 42 clinical genetics (m.d.) providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RavictiGlycerol Phenylbutyrate | 13 | $1,496,677 |
| Sapropterin Dihydrochloride | 24 | $185,606 |
| Miglustat | 12 | $136,800 |
Paid to pharmacies, not to this prescriber.
Other clinical genetics (m.d.) in Cleveland
- Angelika ErwinCleveland$225K
- Xiangling WangCleveland$4K
- Rocio MoranCleveland$1K
- Jirat ChenbhanichCleveland$384
- Charis EngCleveland$321
- Jessica OgawaCleveland$184
- Aditi YadavCleveland$168
- Aditi ParikhCleveland$94
- Kirkland WilsonCleveland$35
- Adnan AlsadahCleveland$33
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.